Publicaciones en colaboración con investigadores/as de Centro de Investigación Biomédica en Red sobre Enfermedades Hepáticas y Digestivas (103)

2024

  1. A Protocol for the Isolation of Oval Cells without Preconditioning

    International Journal of Molecular Sciences, Vol. 25, Núm. 19

  2. An altered expression of miR-376a-3p and miR-20a-5p in peripheral blood exosomes regulates the autophagy and inflammatory systemic substrates, and relates to the smoking habit and age in Crohn's disease

    FASEB Journal, Vol. 38, Núm. 2

  3. Beneficial effects of hepatic cyclooxygenase-2 expression against cholestatic injury after common bile duct ligation in mice

    Liver International, Vol. 44, Núm. 9, pp. 2409-2423

  4. Crosstalk between P2Y receptors and cyclooxygenase activity in inflammation and tissue repair

    Purinergic Signalling, Vol. 20, Núm. 2, pp. 145-155

  5. Inhibition of ALK3-mediated signalling pathway protects against acetaminophen-induced liver injury

    Redox Biology, Vol. 71

  6. Iron chelation as a new therapeutic approach to prevent senescence and liver fibrosis progression

    Cell Death and Disease, Vol. 15, Núm. 9

  7. Protein kinase D2 modulates hepatic insulin sensitivity in male mice

    Molecular Metabolism, Vol. 90

  8. The hepatocyte epidermal growth factor receptor (EGFR) pathway regulates the cellular interactome within the liver fibrotic niche

    Journal of Pathology, Vol. 263, Núm. 4-5, pp. 482-495

  9. Uncovering a Novel Functional Interaction Between Adult Hepatic Progenitor Cells, Inflammation and EGFR Signaling During Bile Acids-Induced Injury

    International Journal of Biological Sciences, Vol. 20, Núm. 7, pp. 2339-2355

2023

  1. Characterization of hepatic fatty acids using magnetic resonance spectroscopy for the assessment of treatment response to metformin in an eNOS−/− mouse model of metabolic nonalcoholic fatty liver disease/nonalcoholic steatohepatitis

    NMR in Biomedicine, Vol. 36, Núm. 8

  2. Circulating bone morphogenetic protein 8A is a novel biomarker to predict advanced liver fibrosis

    Biomarker Research, Vol. 11, Núm. 1

  3. Corrigendum to “Downregulation of Thioredoxin-1-dependent CD95 S-nitrosation by Sorafenib reduces liver cancer” [Redox Biol. 34 (2020) 101528] (Redox Biology (2020) 34, (S2213231720304882), (10.1016/j.redox.2020.101528))

    Redox Biology

  4. Defining the metabolic signatures associated with human macrophage polarisation

    Biochemical Society transactions, Vol. 51, Núm. 4, pp. 1429-1436

  5. Immunometabolic actions of trabectedin and lurbinectedin on human macrophages: relevance for their anti-tumor activity

    Frontiers in Immunology, Vol. 14

  6. Increased let-7d-5p in non-alcoholic fatty liver promotes insulin resistance and is a potential blood biomarker for diagnosis

    Liver International, Vol. 43, Núm. 8, pp. 1714-1728

  7. Maresin 1 activates brown adipose tissue and promotes browning of white adipose tissue in mice

    Molecular Metabolism, Vol. 74

  8. New and Old Key Players in Liver Cancer

    International Journal of Molecular Sciences, Vol. 24, Núm. 24

  9. Nicotinamide N-methyltransferase (NNMT) regulates the glucocorticoid signaling pathway during the early phase of adipogenesis

    Scientific Reports, Vol. 13, Núm. 1

  10. Protective effects of the succinate/SUCNR1 axis on damaged hepatocytes in NAFLD

    Metabolism: Clinical and Experimental, Vol. 145

  11. Saturated fatty acid-enriched small extracellular vesicles mediate a crosstalk inducing liver inflammation and hepatocyte insulin resistance

    JHEP Reports, Vol. 5, Núm. 8